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Background: Emphysema induced by cigarette smoking is characterized by an inflamma-
tory process, which is resistant to steroid and remains active in lung tissue long after
smoking has stopped. Latent adenoviral infection (Ad5) increases emphysema develop-
ment and the inflammatory response to cigarette smoke and, in allergic lung inflammation,
suppresses anti-inflammatory effects of steroids.
Objectives: The present study was designed to examine the effect of smoking cessation
and steroid treatment on lung emphysema and inflammation in a guinea pig model of
emphysema and to determine if latent adenoviral infection induces resistance to the
inflammatory effects of steroid.
Methods: Latent adenovirus or sham infected animals exposed to room air or cigarette
smoke for 16 weeks were either sacrificed immediately or treated with dexamethasone or
diluent for an additional 5 weeks without smoke exposure. Lung morphometry,
inflammatory cells and mediators were studied.
Results: Smoking cessation was associated with an increase in lung surface area and
surface area to volume ratio. Smoking cessation was also associated with decreases in lung
neutrophils, CD4 cells, and IL-8, RANTES and IFN-g mRNAs to control levels. Steroid
treatment significantly lowered neutrophils, eosinophils and IFN-g mRNA and, while
adenoviral infection did not alter these steroid-induced changes, it independently
increased airway wall neutrophils and CD8 cells.
Conclusion: smoking cessation decreases lung inflammation and latent adenoviral
infection does not induce steroid resistance in this animal model.
& 2007 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
6 4747; fax: +418 656 4762.
aval.ca (J. Milot).
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J. Milot et al.2328Introduction
The cigarette smoking habit induces lung inflammation in
everyone and this response is amplified in the 15–20% of
smokers who develop chronic obstructive pulmonary disease
(COPD). This inflammatory process1,2 is characterized by an
increase in neutrophils, macrophages and CD4 and CD8
T-lymphocytes.
While smoking cessation slows the rate of decline in
FEV1,
3 other studies2,4,5 indicate that the inflammatory
process remains active in lung tissue long after smoking has
stopped. Steroid treatment has no effect on the rate of
decline in lung function in COPD6 but can prevent exacer-
bations and improve quality of life. No study has investi-
gated the effect of steroid treatment on the inflammatory
process in individuals who have stopped smoking, particu-
larly with respect to the changes in lung histology associated
with this dual intervention. Steroids decrease neutrophil
apoptosis in vitro7 and reports of short-term steroid
treatment in patients with COPD suggest that steroids fail
to reduce the number of neutrophils or their proteolytic
activity in induced sputum from COPD patients.8–10
Chronic exposure of guinea pigs to cigarette smoke
produces lesions similar to those seen in centrilobular
emphysema in humans11 and we found that latent adenovir-
al infection amplified both cigarette smoke-induced lung
inflammation and the severity of emphysema.12 Other
studies from our laboratory13 have also shown that latent
adenoviral infection induces steroid resistance in allergen
(ovalbumin)-induced lung inflammation in these animals.
The present study was designed to examine the effect of
smoking cessation and steroid treatment on lung emphyse-
ma and inflammation in this guinea pig model of emphysema
and to test the hypothesis that latent adenoviral infection
induces resistance to the anti-inflammatory effects of
steroid in this setting.
Materials and methods
Study design
This experiment was completed in two phases. Table 1 shows
the way in which guinea pigs were randomized and the
number of animals in each of the experimental groups. We
exposed one group of sham (control) or infected animals
(see below) to room air while another set of animals were
exposed to cigarette smoke for 16 weeks followed by
sacrifice (phase 1). A second set of latent adenoviral or
sham infected animals received a similar 16 weeks of smoke
exposure followed by 5 weeks in room air with or without
steroid treatment prior to sacrifice and one group of sham
(control) or infected animals received room air for all 21
weeks (phase 2, Table 1). The 5 weeks of room air exposure
was to determine the effect of smoking cessation on
inflammation induced by smoke exposure. Dexamethasone
treatment during this smoking cessation period was to
determine if steroids could reverse the smoke-induced
inflammatory response and if latent adenovirus infection
could induce steroid resistance The Committee on Animal
Care of the University of British Columbia approved these
studies.Animals
Female guinea pigs (Cam Hartley, 300–350 g) were pur-
chased from Charles River (St. Constant, Quebec, Canada).
Animals were provided with food and water ad libitum and
their body weights were measured weekly throughout the
experimental period.
Adenoviral infection
Wild type adenovirus five was obtained from the American
Type Culture Collection (Rockville, MD, USA). The virus was
propagated in monolayer cultures of A549 cells and purified
as previously described.12 For sham infections, non-infected
A549 cells were cultured and processed as the infected
cells.
Animals were anesthetized with Halothanes and then
given either 109.2 ID50 of purified adenovirus or the
equivalent volume of the sham infection preparation in
200 ml PBS intranasally. The infected animals were kept in
containment for 21 days to allow latent infection to be
established.12 The presence of latent adenoviral infection
was confirmed by TCID50 assay of the lung homogenates and
by in situ hybridization of paraffin-embedded lung sections
from three adenovirus infected animals 7 days post-
infection while a corresponding sham infected animal served
as a negative control (data not shown).
Cigarette smoke exposure
After 21 days, awake animals were exposed to non-filtered
cigarette smoke or room air using a previously described
method and apparatus.12 These smoke and room air
exposures took place over a 16-week period. At the end of
16 weeks, phase 1 animals were sacrificed.
Steroid treatment
At the end of 16 weeks, smoke exposure was stopped in
phase 2 animals. Some of these animals were treated during
the next 5 weeks with a daily oral dose of 10mg/kg of
dexamethasone C22H29FO5 (Ultrapure from USB) diluted in
5% D-glucose solution or received an equal volume of the
vehicle delivered in the same way while animals not exposed
to cigarette smoke received neither (Table 1). The dose and
the route of administration of the dexamethasone were
based on preliminary work done in our laboratory.
Lung tissue preparations
All animals were coded then euthanized with an intraper-
itoneal overdose of pentobarbital. After sacrifice, animals in
the first phase that were exposed to cigarette smoke for 16
weeks had their lungs removed and their right upper and
lower lobes inflated and fixed in 10% buffered formalin and
lung volume measured by water displacement normalized to
body weight to serve as a reference volume for morpho-
metric analysis. These two lobes were processed into
paraffin blocks to provide the histological sections required
for morphometric and immunohistochemical analysis.12 The
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Table 1 Study design and number of animals.
Study
Phase 1
Week 1–16
Sham Air (control) - Sacrifice (5)
Smoke - Sacrifice (5)
Ad Air - Sacrifice (5)
Phase 2
Week 1–16 stop Week 17–21(Air)
Sham
Air (control) - No treatment - Sacrifice (8)
Smoke - Vehicle - Sacrifice (10)
Smoke - Dex - Sacrifice (10)
Ad
Air - No treatment - Sacrifice (8)
Smoke - Vehicle - Sacrifice (9)
Smoke - Dex - Sacrifice (9)
Phase 1: Sham-infected guinea pigs were exposed to cigarette smoke for 16 weeks or room air and then sacrificed. Phase 2: Guinea pigs
were Ad or sham-infected and exposed to cigarette smoke or room air for 16 weeks followed by 5 weeks at room air before they were
sacrificed. Ad or sham-infected animals exposed to cigarette smoke were randomized to received Dex or vehicle during the 5 weeks of
room air exposure while Ad or sham-infected 16 week air control received neither. Dex: dexamethasone, Ad: Latent adenovirus
infection, (n).
Smoking cessation, steroids and emphysema 2329right middle lobe was frozen in liquid nitrogen and stored at
70 1C for RNA extraction. The left lung was inflated in a 1:1
mixture of PBS (pH 7.4) and CryoMatrix (Tissue-Tek, Miles
Inc., Elkhart, IN, USA), snap frozen in liquid nitrogen then
stored at 70 1C for use in immunohistochemical analysis.
Lung tissues from the animals in phase 2 were processed in a
similar manner except for the following differences. The
right upper and middle lobes were directly processed for
RNA extraction; the right lower lobe processed as above for
immunohistochemical analysis of frozen sections while the
left lung inflated with 10% buffered formalin for paraffin
embedding.
Lung morphometry
To determine the alveolar surface area (SA), lung SA/volume
ratio and volume fractions of lung compartments (alveolar
tissue, airspace and airway wall) sections cut from the
paraffin blocks onto glass slides were stained with hemato-
xylin and eosin. Whole mount scans of glass slides were used
first for dissecting the parenchymal from the non-parench-
ymal tissue such as large conducting airways and blood
vessels. In order to provide a coefficient of error o0.1, at
least five fields per slide were randomly selected. All the
fields were captured using a 10 objective by the Cool Spot
digital camera and images were analyzed using ImagePro
Plus software. A multilevel cascade design14 was used to
determine the volume fractions (Vv) of lung tissue, airspace,
airway wall, airway lumen and lung surface density (Sv). The
total SA of lung parenchyma was calculated by multiplying Sv
by the total lung volume.
Immunohistochemical analyses
T-lymphocyte subsets and macrophages were identified by
immunostaining of frozen serial sections fixed in 10%formalin.12 Neutrophils and eosinophils were identified on
subsequent serial sections stained with diaminobenzidine
and Hansel’s method, respectively. The accumulated volume
of specifically stained cells located in the parenchyma or
airway wall was determined by point counting images
captured using light microscopy as previously described.12
By applying the multilevel cascade design this volume was
expressed as total stained cell volume (ml) per kg of body
mass.
RNA extraction
Approximately 2 g of frozen inflated lung tissue from phase 1
animals sacrificed after smoke exposure were homogenized
in 15ml of lysis buffer supplied by the RNeasy Maxi Kit
(Qiagen, Mississauga, Ont., Canada). The homogenate was
frozen in liquid nitrogen and stored at 70 1C until RNA was
extracted. Similarly RNA was extracted from approximately
0.6 g of non-inflated tissue from the right upper and middle
lobes of phase 2 animals.
Real-time PCR of IL-8 and RANTES and semi-
quantitative PCR of IFN-c mRNA
One mg of total RNA, previously treated with DNAse, was
reverse transcribed using the murine Moloney leukemia virus
reverse transcriptase and random hexamers. PCR for IL-8,
RANTES, IFN-g, and 18S used primers listed in Table 2, SYBR
Green PCR core reagents and a real-time PCR Applied
Biosystems Prism 7600 sequence detector (Applied Biosys-
tems, Foster City, CA, USA) following manufacturer’s
instructions. The concentration for IL-8, RANTES and 18S
rRNA in the samples was determined using standard curves
from their respective cDNA. IL-8 and RANTES mRNA
concentrations were normalized to that of the correspond-
ing 18S rRNA. Because the expression of IFN-g in these
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Table 2 PCR primers used to amplify inflammatory mediator mRNAs.
Mediator Sequences Reference
IL-8 15
Forward 50-GGCAGCCTTCCTGCTCTCT-30
Reverse 50-CAGCTCCGAGACCAACTTTGT-30
RANTES 16
Forward 50-TGCTGCTGCTTGTTCTGGTCTT-30
Reverse 50-GCAGGGCCTCGATAGCTCTTT-30
IFN-g Gene Bank: gi13024975
Forward 50-TCAGAGCCAAATCGTCTCCTTC-30
Reverse 50-GTTCGGTGACAGGTCATCTATC-30
18S rRNA 15
Forward 50-TGCATGGCCGTTCTTAGTTG-30
Reverse 50-AGTTAGCATGCCAGAGTCTCGTT-30
J. Milot et al.2330samples was low and could not be quantified reliably by real-
time PCR, PCR products amplified after 35 cycles were,
therefore, detected on ethidium bromide stained agarose
gels and the band representing the IFN-g product was
analyzed semi-quantitatively with the NIH Imaging Soft-
ware. The density of the IFN-g bands was compared to IFN-g
cDNA standards run on the same gel before normalizing to
the corresponding 18S rRNA from above.Statistical analysis
A nested model of analysis of variance was used to assess the
relevant effects of smoking cessation, steroid treatment and
latent adenoviral infection on lung volume, SA, SA to volume
ratio and the volumes of the inflammatory cells; each main
effect and interaction was tested using a contrast.17 The
analyses of IL-8, RANTES, IFN-g, were performed using two-
way ANOVA. The normality assumption was verified with the
Shapiro–Wilk test and the Brown and Forsythe’s variation of
Levene’s test statistic was used to verify the homogeneity of
variances. After performing these tests on raw data, all p-
values were o0.05, meaning that these assumptions were
not fulfilled and were rejected. The graphical analyses of
residuals with predicted values revealed a relationship
between the variances of the observations and the means
for these variables. To estimate the form of the required
transformation associated to these variables, a regression
approach was performed between the logarithm of the
standard deviations and the logarithm of the means from
different conditions. This approach was useful to stabilize
the variance.17 Some of the parameters were log trans-
formed (RANTES/18S) and an inverse transformation (IL-8/18S,
IFN-g/18S) was applied to the others. As normality assump-
tions were not obtained for some transformed parameters, a
generalized linear model using a gamma distribution with an
inverse link function was used. Results from these statistical
models were similar to ones obtained from the ANOVA on
transformed data. Statistical results from these parameters
were expressed with transformed values. The Tukey’smultiple comparison technique was applied post hoc to
the ANOVA. The results were considered significant with
p-values p0.05. The data were analyzed using the statis-
tical package program SAS v8.2 (SAS Institute Inc., Cary, NC,
USA).
Results
Weekly recordings of body weights during the smoke
exposure periods showed similar overall weight gain in the
control and treated animals in both phase 1 and 2 studies
(data not shown). Cortisol levels measured at the end of
study were lower in the dexamethasone-treated animals
versus vehicle-treated ones (1045 nmol/l, n ¼ 19 versus
1648 nmol/l, n ¼ 19; p ¼o0.00001). Although steroid
treatment resulted in a slower rate of weight gain, the
final weights were not different between any of the groups
(p40.05).
Because of the variability of the control groups between
the two separate sets of experiments (smoking and smoking
cessation protocol) we decided to express the results
relative to their respective controls. Furthermore, when
we compared the normalized values to those expressed as
absolute values we found that the conclusions reached
remain unchanged whether the data was expressed as ratios
or as absolute values (data not presented).
Emphysematous changes
Animals exposed to smoke until sacrifice and those where
smoking was stopped 5 weeks prior to sacrifice were
compared to their respective sham room air controls
(Table 1). Smoke exposure increased lung volume (Figure 1A)
and decreased lung SA/volume ratio (Figure 1B) but did not
change lung SA (Figure 1C). When the same level of smoke
exposure was followed by 5 weeks of smoking cessation,
lung volumes remained high (Figure 1A) but the lung SA/
volume ratio increased (Figure 1B). Surprisingly, there was a
significant increase in lung SA (Figure 1C) following smoking
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Smoking cessation, steroids and emphysema 2331cessation with no additional effect with either latent
adenoviral infection or steroid treatment.
Parenchyma inflammation
Inflammatory responses in the lung parenchyma of animals
from the two phases compared to their respective controls
(Figure 2) showed the following. Parenchymal neutrophils
were increased after the smoke exposure and smoking
cessation lowered neutrophil counts to control levelsLung Volume (ml)
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Figure 1 The independent and combined effects of smoke
exposure (smk), smoke cessation (smk+stop), latent adenoviral
(ad) infection and steroid treatment (dex) on total lung volume
(A), lung surface area to volume ratio (B) and surface area (C) of
the lung. Each treatment group is normalized to its respective
sham infected, room air control (control) where the values
were 22.773.25 and 23.970.74ml (A), 43779.54 and 6137
14.8 cm2/ml (B), and 10,8007415.8 and 14,5957452.5 cm2
(C) for phase 1 and 2 controls, respectively. Data are presented
as a % of change compared to control7S.E.M. *Main effect
of smoke exposure (A, p ¼ 0.04) and (B, p ¼ 0.001); fMain
effect of stopping smoking (A, p ¼ 0.0001), (B, p ¼ 0.0001) and
(C, p ¼ 0.0001).independently of latent adenoviral infection (Figure 2A).
The administration of steroid during the smoke cessation
period had an independent effect in lowering these
neutrophil counts in the parenchyma below control levels
and this was not influenced by latent adenoviral infection
(Figure 2A). Smoke exposure increased parenchymal macro-
phages, stopping smoke did not fully reverse this while
adenovirus or steroid had no additional effect (Figure 2B).
The analysis of the inflammatory response showed that
following smoke exposure and cessation, both the parench-
ymal CD4 and CD8 T-lymphocytes were not statistically
different between the groups (data not shown).Airway inflammation
Analysis of the airway wall showed that smoke exposure
increased neutrophils while smoking cessation allowed their
numbers to return to control values (Figure 3A). Latent
adenoviral infection also caused an increase in neutrophils
despite smoking cessation. Steroid treatment independently
lowered their counts below control levels (Figure 3A).4
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Figure 2 The response of parenchymal neutrophils (A) and
macrophages (B) to smoke exposure, smoke cessation, latent Ad
infection and steroid treatment. The designation of the
treatment groups and controls are the same as in Figure 1.
Absolute volumes of each cell type were determined by the
multilevel sampling design and analyzed using ANOVA. Each
treatment group is normalized to its respective control where
the volumes of neutrophils are 0.10370.05 and 0.18970.03ml/kg
(A), and the volumes of macrophages are 0.07170.02 and
0.39170.04ml/kg (B) for phase 1 and 2 controls, respectively.
*Main effect of smoke exposure (A, p ¼ 0.0001), (B, p ¼ 0.001);
z(B, p ¼ 0.0004 compared to control); yMain effect of steroid
treatment (A, p ¼ 0.0005).
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J. Milot et al.2332Airway wall eosinophils were markedly reduced by steroid
treatment but neither latent adenovirus, smoke exposure,
nor stopping smoking had any effect (Figure 3B). CD4
lymphocytes in the airway were only affected by cigarette
smoke which led to their increase while smoking cessation
allowed them to return to control values (Figure 3C). CD8
T-cells, in contrast, were only affected by latent adenoviral
infection, which independently led to their increase
(Figure 3C).
Inflammatory mediator expression
IL-8 expression increased only in uninfected animals after
smoke exposure (Figure 4A). IL-8 expression was not
affected by latent adenovirus alone (data not shown) or by
latent adenovirus infection or steroid treatment after
stopping smoking but smoking cessation returned it to
control levels (Figure 4A). Cigarette smoke exposure3.0
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Figure 3 The response of airway wall neutrophils (A), eosinophi
cessation, latent Ad infection and steroid treatment. The designation
Absolute volumes of each cell type were determined by the multile
group is normalized to its respective control where the volumes of
volumes of eosinophils are 0.04370.007 and 0.02170.004ml/kg (B
(C) and the volumes of CD8 are 0.00970.0008 and 0.05570.0005m
smoke exposure (A, p ¼ 0.0002) and (C, p ¼ 0.001); yMain effect o
effect of steroid treatment (A, p ¼ 0.0001) and (B, p ¼ 0.0002).increased RANTES mRNA levels in the guinea pig lungs
(Figure 4B) and its expression returned to control levels
after 5 weeks of smoking cessation. Neither latent adeno-
viral infection alone (data not shown) or in combination with
smoking cessation nor steroid treatment altered RANTES
expression (Figure 4B). IFN-g mRNA was also increased by
smoke exposure (Figure 4C) and returned to respective
control levels after smoking cessation (Figure 4C). Latent
infection alone did not have any effect (data not shown).
Steroid treatment significantly decreased IFN-g mRNA
compared to control while latent adenovirus infection had
no additional effect (Figure 4C).
Discussion
The results of these animal studies demonstrate that
smoking cessation reduced lung inflammation and increased
lung SA suggesting that tissue repair processes were3
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ls (B), CD4 (C) and CD8 (D) T-cells to smoke exposure, smoke
of the treatment groups and controls are the same as in Figure 1.
vel sampling design and analyzed using ANOVA. Each treatment
neutrophils are 0.02170.001 and 0.05170.004ml/kg (A), the
), the volumes of CD4 are 0.0270.003 and 0.10870.024ml/kg
l/kg (D) for phase 1 and 2 controls, respectively. *Main effect of
f latent Ad infection (A, p ¼ 0.005), and (D, p ¼ 0.007); yMain
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Figure 4 Inflammatory mediator mRNA expression in lungs of
guinea pigs. Results of quantitative real-time PCR of IL-8 (A) and
RANTES (B) mRNA normalized to the corresponding 18S rRNA
expression and semi-quantitative PCR of IFN-g mRNA (C)
normalized to 18S rRNA. Each treatment group is normalized
to its respective control where IL-8/18S ratios are
0.001670.0002 and 0.00570.007 (A), RANTES/18S ratios are
0.001570.001 and 0.005770.001 (B) and IFN-g/18S ratios
are 0.0000370.00007 and 0.005270.001 (C) for phase 1 and 2
controls, respectively. See Figure 1 for treatment group
designations. *Main effect of smoke exposure (A, p ¼ 0.037),
(B, p ¼ 0.004) and (C, p ¼ 0.009); yMain effect of steroid
treatment compared to control (C, p ¼ 0.001).
Smoking cessation, steroids and emphysema 2333initiated by smoking cessation. Latent adenoviral infection
was also associated with lung inflammation but did not
induce steroid resistance.
Smoking cessation was also associated with a decrease in
CD4 cells, a reduction of neutrophil infiltration to control
levels and a partial reversal of macrophage infiltration
toward control values. These findings contrast sharply with
those observed in several human studies2,4,5 where an active
inflammatory process persists in the lung long after stopping
smoking. We suspect that the distinction between human
and guinea pig is related to a relative difference in level of
smoke exposure that can be achieved in rodents compared
to that received by humans with a long term smoking habit.
Retamales et al.2 reported that mild human emphysema
resulted in a reduced SA/volume ratio with preservation of
the SA indicating that the earliest lesions are related to an
increase in lung volume whereas severe human disease was
associated with a marked destruction of the lung’s SA.
Although exposure to cigarette smoke has produced theequivalent of mild disease in several animal models we are
unaware of any animal experiment that has produced the
level of lung destruction observed in human emphysema.
In this study, steroid treatment reduced the accumulated
volume of infiltrating neutrophils below that achieved by
stopping smoking in both the lung parenchyma and airway
wall with or without latent adenoviral infection while
studies of induced sputum in COPD indicate that steroid
treatment is not effective in reducing neutrophils.8–10
Steroids also reduced eosinophil infiltration into airway
walls whether latent adenoviral infection was present or
not. These results indicate that latent adenoviral infection
does not confer steroid resistance to cigarette smoke-
induced lung inflammation in guinea pigs even though it can
block the anti-inflammatory effects of steroids in allergen-
induced eosinophil infiltration by preventing the down
regulation of eotaxin production by steroids.18 Latent
adenovirus, however, can contribute to the inflammatory
process, as shown in this study, by increasing airway wall
neutrophils and CD8 cells. Decreases in inflammatory cells as
a consequence of stopping smoking discussed above may
relate to similar reversals currently demonstrated in the
smoke-induced increased expression of inflammatory med-
iators. Decreased expression of IL-8, a cytokine that is
chemotactic for neutrophils,19 when smoke exposure was
stopped, is likely the reason why less neutrophils are found
in the parenchyma at this time. Interestingly, IL-8 levels in
sputum of COPD patients who had quit smoking for at least 1
year did not decrease.20 However, IL-8 levels did not change
following steroid treatment as also observed by Keatings
et al.21 after 2 weeks of oral steroid in COPD patients. Other
factors that are important in neutrophil migration include
the expression of adhesion molecules ICAM-1. Studies have
reported an increase of ICAM-1 in lungs of COPD patients22,23
suggesting that neutrophils and the endothelium have been
activated, and this is supported by the observation that
circulating neutrophils from COPD patients have increased
surface expression of ICAM-1 receptor CD11b compared to
controls.24 Steroid are known to down regulate the expres-
sion of CD11b on neutrophils25 suggesting that decrease of
neutrophil count following steroid treatment could be
associated with a decrease of their recruitment in the lung.
Similarly, decreased RANTES, a chemokine attracting
monocytes/macrophages and T-cells,26 could account for
decreased CD4 T-cells as well as the partial reversal of the
smoke-induced macrophage infiltration. The latter is sup-
ported by accumulation of BAL macrophages after tracheal
instillation of RANTES in guinea pigs.27 RANTES is upregulated
in stable COPD but this increase is more important during
acute exacerbations frequently associated with bronchial
eosinophilia.28 Our current result is the first report showing
that cigarette smoke can upregulate RANTES expression in the
absence of eosinophilic infiltration.12 Galkina et al.29 found
that pulmonary RANTES expression contributes to the active
CD8 T-cell transmigration into the normal interstitium through
a pertussis toxin-sensitive (PTX-sensitive) signaling mechanism
that is not dependent on inflammation. In this study, RANTES
expression is not associated with CD8 modulation. Surprisingly,
RANTES was resistant to steroid treatment in our model
whereas when it is associated with an eosinophilc infiltration,
RANTES expression is reduced by steroid in an allergic lung
inflammation model.18
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J. Milot et al.2334There is increasing evidence that COPD has a type 1 T-cell
cytokine profile with an increase in IFN-g expression.30–34
Interestingly, Wang et al.35 used a mouse model with an
inducible IFN-g gene to show that the over-expression of IFN-g
can cause emphysema and an alteration in the pulmonary
protease/antiprotease balance. The relationship between
IFN-g and inflammatory cells mainly focuses on lymphocytes.
As this is the signature cytokine for the TH1 subset of CD4
lymphocytes,36 its decrease with smoking cessation may be
reflective of similar decreases in CD4 cells. On the other
hand, IFN-g can activate macrophages to indirectly increase
chemotaxis of specific T-cells.37 Also, of the mediators
studied, only IFN-g was reduced by steroid treatment. The
inhibition of transcription and synthesis of IFN-g by
corticosteroids was demonstrated in both in vivo and in
vitro studies, using both resting T-cells as well as effector
T-cell clones.38,39 Indirectly, corticosteroids affect T-cell by
inhibiting macrophage IL-12, a cytokine that is extremely
potent in enhancing type 1 immune responses by inducing
the lytic function of cytotoxic CD8 T-cells. IL-12 also
enhances the production of IFN-g and IL-2 by T-cells. The
reduced production of IL-12 by corticosteroid-treated
macrophages resulted in a decreased ability to induce IFN-g
by T-lymphocytes.40 IL-12 expression is increased in smokers
and COPD patients and inhaled steroid decreased the IL-12
levels with dose dependency in stable COPD.41 So while
IFN-g expression is returned to control levels by smoking
cessation, corticosteroids could reduce IFN-g expression
even further either directly by affecting T-lymphocytes
or indirectly by inhibiting IL-12 expression by macrophages.
Our results indicate that smoking cessation increased the
SA of the lung suggesting that lung tissue damaged by smoke
undergoes some levels of repair in this animal model.
Increases in SA that occur during lung development results
from a septation process that adds alveoli to alveolar ducts.
Although this process is thought to be complete at birth in
guinea pigs,42 our data raise the possibility that it might be
reawakened during the repair processes that occur following
the cessation of smoking. In an attempt to support this
repair process, we analyzed the expression of both
proliferating cell nuclear antigen, a cell proliferation
marker, and TGF-b1 but results were inconclusive (data
not presented), most likely because we had to rely on an
antibody specific for the human form of these proteins,
for lack of guinea pig specific ones. The mechanism of
tissue destruction by smoke exposure has been studied in
guinea pigs where smoke-induced increased collagenase43
levels, as well as attenuation of tobacco smoke-induced
emphysema by a broad spectrum MMP inhibitor,44 have been
reported. The mechanism of tissue repair after smoking
cessation in this model, however, requires further investiga-
tion in order to support our preliminary, but nonetheless
novel, evidence that smoking cessation results in a repair
process.
We conclude that smoking cessation diminishes cigarette
smoke-induced lung inflammation and initiates tissue repair.
Latent adenovirus contributes to the inflammatory process
without inducing steroid resistance. The addition of steroid
therapy further reduces IFN-g expression and the infiltration
of neutrophils and eosinophils. Most importantly the repair
process associated with stopping smoking includes an
increase in the SA that may be associated with an awakeningof the septation process that increases alveolar number and
SA during lung growth.
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